ANTI-PD-L1 DIABODIES AND THE USE THEREOF

Provided are anti-PD-L1 diabodies, imaging agents, methods and kits for determination of the distribution and expression levels of PD-L1 in an individual having a disease or condition. Anti-PD-L1 diabody agents, and methods for treating diseases or disorders are also provided. L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors WEN, Zhenguo, LUO, Liqun, LIU, Qianyong, CHEN, Lieping
Format Patent
LanguageEnglish
French
Published 30.07.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided are anti-PD-L1 diabodies, imaging agents, methods and kits for determination of the distribution and expression levels of PD-L1 in an individual having a disease or condition. Anti-PD-L1 diabody agents, and methods for treating diseases or disorders are also provided. L'invention concerne des di-anticorps anti-PD-L1, des agents d'imagerie, des procédés et des kits pour la détermination des niveaux de distribution et d'expression de PD-L1 chez un individu souffrant d'une maladie ou d'un trouble. L'invention concerne également des agents de di-anticorps anti-PD-L1, et des procédés de traitement de maladies ou de troubles.
Bibliography:Application Number: WO2020CN72572